Mustang Bio, Inc. (MBIO)
NCM – Real vaqt narxi. Valyuta: USD
0.72
-0.02 (-2.28%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.73
+0.01 (1.51%)
Bozordan keyin: Mar 27, 2026, 7:46 PM EDT

NCM – Real vaqt narxi. Valyuta: USD
0.72
-0.02 (-2.28%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.73
+0.01 (1.51%)
Bozordan keyin: Mar 27, 2026, 7:46 PM EDT
Mustang Bio, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda davolash qiyin bo'lgan saraton va otoimmün kasalliklar uchun hujayra terapiyalarini muolajalarga aylantirishga qaratilgan. Kompaniya MB-106ni ishlab chiqadi, bu CD20-ni nishonga olgan kimera antigen retseptorli (CAR) T-hujayra terapiyasi bo'lib, u limfoma, surunkali limfotsitar leykemiya va otoimmün kasalliklar uchun I bosqich klinik sinovlarida; MB-109, IL13Rα2+ takrorlanuvchi yoki refrakter glialblastoma va yuqori darajali astrositoma uchun potentsial davolash sifatida MB-101 va MB-108 ning kombinatsiyasi; MB-101, glialblastoma uchun I bosqichni yakunlagan IL13Ra2 CAR T-hujayra dasturi; va herpes simplex virusi-1 onkolitik virusi C134ni davolash uchun I bosqichda bo'lgan MB-108. Kompaniya City of Hope National Medical Center va Nationwide Children's Hospital bilan litsenziya shartnomasiga ega. Mustang Bio, Inc. 2015-yilda tashkil etilgan va shtab-kvartirasi Uoltem, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Manuel Litchman M.D. | President, CEO, Interim CFO & Director |
| Mr. Greg Furrow M.S. | Chief Quality Officer |
| Mr. Michael S. Weiss Esq., J.D. | Executive Chairman |
| Mr. Peter Carney | Controller & Interim Chief Accounting Officer |
| Ms. Robyn M. Hunter | Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-19 | 10-K | tmb-20251231x10k.htm |
| 2025-12-23 | 8-K | tmb-20251217x8k.htm |
| 2025-12-03 | DEF 14A | tmb-20251222xdef14a.htm |
| 2025-11-07 | 10-Q | tmb-20250930x10q.htm |
| 2025-08-08 | 10-Q | tmb-20250630x10q.htm |
| 2025-07-09 | 8-K | tm2520081d1_8k.htm |
| 2025-05-14 | 10-Q | tmb-20250331x10q.htm |
| 2025-04-04 | POS AM | tm2511481d1_posam.htm |
| 2025-04-01 | POS EX | tm2510938d1_posex.htm |
| 2025-03-28 | 10-K | tmb-20241231x10k.htm |